CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 401–500 of 1,013
Zhu, Y., Shen, R., Vuong, I., Reynolds, R. A., Shears, M. J., Yao, Z., Hu, Y., Cho, W. J., Kong, J., Reddy, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31993-y · Cited by 168
Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice
Henry, S., Stecker, K., Brooks, D., Monteith, D., Conklin, B., & Bennett, C. F. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35315-7 · Cited by 151
Pérarnau, B., Saron, M.-F., San Martin, B. R., Bervas, N., Ong, H., Soloski, M. J., Smith, A. G., Ure, J. M., Gairin, J. E., & Lemonnier, F. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1243::aid-immu1243>3.0.co;2-a · Cited by 186
Imaging activated T cells predicts response to cancer vaccines
Alam, I. S., Mayer, A. T., Sagiv-Barfi, I., Wang, K., Vermesh, O., Czerwinski, D. K., Johnson, E. M., James, M. L., Levy, R., & Gambhir, S. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98509 · Cited by 156
CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation
Milas, L., Mason, K. A., Ariga, H., Hunter, N., Neal, R., Valdecanas, D., Krieg, A. M., & Whisnant, J. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0926 · Cited by 151
Self-citationPhosphorothioate antisense oligodeoxynucleotides: questions of specificity
Stein, C. A. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)20006-x · Cited by 151
Ghia, P., Strola, G., Granziero, L., Geuna, M., Guida, G., Sallusto, F., Ruffing, N., Montagna, L., Piccoli, P., Chilosi, M., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1403::aid-immu1403>3.0.co;2-y · Cited by 271
Self-citationSanteliz, J., Nest, G. V., Traquina, P., Larsen, E., & Wills-Karp, M. A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122156 · Cited by 150
Romano, G., Micheli, P., Pacilio, C., & Giordano, A. (2000) · STEM CELLS · doi:10.1634/stemcells.18-1-19 · Cited by 149
DNA activates human immune cells through a CpG sequence‐dependent manner
Bauer, M., Heeg, K. M., Wagner, H., & Lipford, G. B. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00811.x · Cited by 151
Ouyang, X., Li, J., Liu, H., Zhao, B., Yan, J., Ma, Y., Xiao, S., Song, S., Huang, Q., Chao, J., et al. (2013) · Small · doi:10.1002/smll.201300458 · Cited by 148
Kuwajima, S., Sato, T., Ishida, K., Tada, H., Tezuka, H., & Ohteki, T. (2006) · Nature Immunology · doi:10.1038/ni1348 · Cited by 152
Ulmer, J. B., SADOFF, J. C., & Liu, M. A. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80042-2 · Cited by 148
Nucleic acid-based drug delivery strategies
Tan, X., Jia, F., Wang, P., & Zhang, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.040 · Cited by 155
Immunostimulatory CpG-Oligodeoxynucleotides Cause Extramedullary Murine Hemopoiesis
Sparwasser, T. D., Hültner, L., Koch, E. S., Luz, A., Lipford, G. B., & Wagner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2368 · Cited by 147
Adjuvant Activity of CpG Oligodeoxynucleotides
Klinman, D. M. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743057 · Cited by 174
Self-citationEwaschuk, J. B., Backer, J. L., Churchill, T. A., Obermeier, F., Krause, D. O., & Madsen, K. L. (2007) · Infection and Immunity · doi:10.1128/iai.01662-06 · Cited by 149
Bonnet, M.-E., Erbacher, P., & Bolcato‐Bellemin, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9693-1 · Cited by 146
Inflammatory bowel disease, past, present and future: lessons from animal models
Mizoguchi, A., & Mizoguchi, E. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2111-3 · Cited by 166
Novel vaccine development strategies for inducing mucosal immunity
Fukuyama, Y., Tokuhara, D., Kataoka, K., Gilbert, R. S., McGhee, Yuki, Y., Kiyono, H., & Fujihashi, K. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.196 · Cited by 165
Casadevall, A., & Pirofski, L. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91001-3 · Cited by 158
CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide
Miconnet, I., Koenig, S., Speiser, D. E., Krieg, A. Μ., Guillaume, P., Cerottini, J., & Romero, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1212 · Cited by 147
Self-citationTranslating nucleic acid-sensing pathways into therapies
Junt, T., & Barchet, W. (2015) · Nature reviews. Immunology · doi:10.1038/nri3875 · Cited by 164
Topical immunomodulators—progress towards treating inflammation, infection, and cancer
Hengge, U. R., Benninghoff, B., Ruzicka, T., & Goos, M. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00095-0 · Cited by 145
Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses
Negishi, H., Yanai, H., Nakajima, A., Koshiba, R., Atarashi, K., Matsuda, A., Matsuki, K., Miki, S., Doi, T., Aderem, A. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2307 · Cited by 159
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.
Liao, J., Gregor, P. D., Wolchok, J. D., Orlandi, F., Craft, D. M., Leung, C., Houghton, A. N., & Bergman, P. J. (2006) · PubMed · Cited by 168
High-mobility group box family of proteins: ligand and sensor for innate immunity
Yanai, H., Ban, T., & Taniguchi, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.005 · Cited by 153
Juliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 160
Immunostimulatory DNA as an Adjuvant in Vaccination againstLeishmania major
Stacey, K. J., & Blackwell, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3719-3726.1999 · Cited by 142
Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides
Brummel, R., & Lenert, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2429 · Cited by 142
Infantino, S., Moepps, B., & Thelen, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2197 · Cited by 171
Zwiorek, K., Bourquin, C., Battiany, J., Winter, G., Endres, S., Hartmann, G., & Coester, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9410-5 · Cited by 141
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
Gäbele, E., Mühlbauer, M., Dorn, C., Weiß, T. S., Froh, M., Schnabl, B., Wiest, R., Schölmerich, J., Obermeier, F., & Hellerbrand, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.096 · Cited by 155
Activation of the immune system by bacterial CpG‐DNA
Häcker, G. A., Redecke, V., & Häcker, H. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01350.x · Cited by 144
Bacterial CpG induces hyper-IgM production in CD27+ memory B cells in primary biliary cirrhosis
Kikuchi, K., Lian, Z., Yang, G., Ansari, A. A., Ikehara, S., Kaplan, M., Miyakawa, H., Coppel, R. L., & Gershwin, M. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.005 · Cited by 145
Watters, C., Fleming, D. F., Bishop, D. K., & Rumbaugh, K. P. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.05.007 · Cited by 160
Hanagata, N. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s114477 · Cited by 142
Antisense therapeutics: is it as simple as complementary base recognition?
Agrawal, S., & Kandimalla, E. R. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01638-x · Cited by 166
CpG DNA Induces Protective Antiviral Immune Responses in Atlantic Salmon (Salmo salarL.)
Jørgensen, J. B., Johansen, L., Steiro, K., & Johansen, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11471-11479.2003 · Cited by 137
CpG DNA redirects class‐switching towards "Th1‐like" Ig isotype production via TLR9 and MyD88
Lin, L., Gerth, A., & Peng, S. L. (2004) · European Journal of Immunology · doi:10.1002/eji.200324736 · Cited by 138
Immunostimulating capacities of stabilized RNA molecules
Scheel, B., Braedel, S., Probst, J., Carralot, J., Wagner, H., Schild, H., Jung, G., Rammensee, H., & Pascolo, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200324198 · Cited by 138
Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.
Carpentier, A. F., Xie, J., Mokhtari, K., & Delattre, J. (2000) · PubMed · Cited by 138
Adjuvants and delivery systems in veterinary vaccinology: current state and future developments
Heegaard, P. M. H., Dedieu, L., Johnson, N., Potier, M. L., Mockey, M., Mutinelli, F., Vahlenkamp, T. W., Vascellari, M., & Sørensen, N. S. (2010) · Archives of Virology · doi:10.1007/s00705-010-0863-1 · Cited by 162
Desmet, C. J., Gosset, P., Pajak, B., Cataldo, D. D., Bentires‐Alj, M., Lekeux, P. M., & Bureau, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5766 · Cited by 147
Weighardt, H., Feterowski, C., Veit, M., Rump, M., Wagner, H., & Holzmann, B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4537 · Cited by 148
Vollmer, J., Weeratna, R. D., Jurk, M., Samulowitz, U., Mccluskie, M. J., Payette, P., Davis, H. L., Schetter, C., & Krieg, A. M. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01962.x · Cited by 138
Self-citationLipford, G. B., Sparwasser, T., Zimmermann, S., Heeg, K., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1228 · Cited by 138
CpG Oligonucleotides as Vaccine Adjuvants
Kayraklioglu, N., Horuluoglu, B., & Klinman, D. M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0872-2_4 · Cited by 146
Self-citationmRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
Rejman, J., Tavernier, G., Bavarsad, N., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.124 · Cited by 151
Guo, Y., Ran, Y., Wang, Z., Cheng, J., Cao, Y., Yang, C., Liu, F., & Ran, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119370 · Cited by 133
Halperin, S. A., Dobson, S., McNeil, S., Langley, J. M., Smith, B. R., McCall-Sani, R., Levitt, D., Nest, G. V., Gennevois, D., & Eiden, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.095 · Cited by 134
Toll-Like Receptor-7 Modulates Immune Complex Glomerulonephritis
Pawar, R. D., Patole, P. S., Zecher, D., Segerer, S., Kretzler, M., Schlöndorff, D., & Anders, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070714 · Cited by 142
Wang, H., Cai, Q., Zeng, X., Yu, D., Agrawal, S., & Zhang, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13989 · Cited by 133
Yi, A., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1240 · Cited by 133
Self-citationCpG oligodeoxynucleotides as immunotherapy in cancer
Jahrsdörfer, B., & Weiner, G. J. (2008) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2007.11.003 · Cited by 132
Toll-Like Receptor 9 Agonists in Cancer
Karapetyan, L., Luke, J. J., & Davar, D. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247050 · Cited by 147
Sanjuan, M. A., Rao, N., Lai, K.-T. A., Gu, Y., Sun, S., Fuchs, A., Fung-Leung, W.-P., Colonna, M., & Karlsson, L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508058 · Cited by 132
Uchijima, M., Yoshida, A., Nagata, T., & Koide, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5594 · Cited by 132
Kline, J. N., Krieg, A. Μ., Waldschmidt, T. J., Ballas, Z. K., Jain, V. V., & Businga, T. R. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70022-9 · Cited by 132
Self-citationCausing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA
Krieg, A. Μ., & Wagner, H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01719-9 · Cited by 132
Self-citationHalperin, S. A., Ward, B. J., Cooper, C., Predy, G., Díaz‐Mitoma, F., Dionne, M., Embreé, J., McGeer, A., Zickler, P., Moltz, K.-H., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.087 · Cited by 140
Dinucleotide and stop codon frequencies in single-stranded RNA viruses.
Rima, B. K., & McFerran, N. V. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-11-2859 · Cited by 131
Roberts, T. L., Sweet, M. J., Hume, D. A., & Stacey, K. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.605 · Cited by 131
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
Martin, H. J., Lee, J. M., Walls, D., & Hayward, S. D. (2007) · Journal of Virology · doi:10.1128/jvi.01122-07 · Cited by 133
Targeting of Toll-like receptors: a decade of progress in combating infectious diseases
Hedayat, M., Netea, M. G., & Rezaei, N. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70099-8 · Cited by 140
Use of CpG oligonucleotides in treatment of asthma and allergic disease
Fonseca, D. E., & Kline, J. N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.007 · Cited by 130
DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents
Alarcon, J. B., Waine, G. J., & McManus, D. P. (1999) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60152-9 · Cited by 133
TLR9 Activation Is Defective in Common Variable Immune Deficiency
Cunningham‐Rundles, C., Radigan, L., Knight, A. K., Zhang, L., Bauer, L., & Nakazawa, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1978 · Cited by 133
Scheu, S., Dresing, P., & Locksley, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808537105 · Cited by 130
Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
Cox, E., Verdonck, F., Vanrompay, D. C. G., & Goddeeris, B. M. (2006) · Veterinary Research · doi:10.1051/vetres:2006014 · Cited by 146
Insight into Graves’ Hyperthyroidism from Animal Models
McLachlan, S. M., Nagayama, Y., & Rapoport, B. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0023 · Cited by 134
Jørgensen, J. B., Johansen, A., Stenersen, B., & Sommer, A.-I. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(00)00068-9 · Cited by 129
Ishii, K. J., Takeshita, F., Gursel, I., Gursel, M., Conover, J., Nussenzweig, A., & Klinman, D. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020773 · Cited by 129
Self-citationOxenius, A., Martinic, M. M. A., Hengartner, H., & Klenerman, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4120-4126.1999 · Cited by 133
Stevenson, J. P., Yao, K.-S., Gallagher, M., Friedland, D. P., Mitchell, E. P., Cassella, A., Monia, B. P., Kwoh, T. J., Yu, R. Z., Holmlund, J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2227 · Cited by 129
Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine
Kojima, Y., Xin, K.-Q., Ooki, T., Hamajima, K., Oikawa, T., Shinoda, K., Ozaki, T., Hoshino, Y., Jounai, N., Nakazawa, M., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00238-4 · Cited by 128
Self-citationIngelsson, B., Söderberg, D., Strid, T., Söderberg, A., Bergh, A.-C., Loitto, V., Lotfi, K., Segelmark, M., Spyrou, G., & Rosén, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711950115 · Cited by 123
de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 127
Phosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?
Krieg, A. Μ., & Stein, C. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.241 · Cited by 127
Self-citationSiewe, L., Bollati–Fogolin, M., Wickenhauser, C., Krieg, T., Müller, W., & Roers, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200636012 · Cited by 127
Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches
Habibi, N., Mauser, A., Ko, Y., & Lahann, J. (2022) · Advanced Science · doi:10.1002/advs.202104012 · Cited by 139
Moscoso, M., & Claverys, J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04305.x · Cited by 153
Ioannou, X. P., Griebel, P. J., Hecker, R., Babiuk, L. A., & den Hurk, S. V. D. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9002-9010.2002 · Cited by 126
The Immune Response Modifiers Imiquimod and R-848 Are Potent Activators of B Lymphocytes
Tomai, M. A., Imbertson, L. M., Stanczak, T. L., Tygrett, L. T., & Waldschmidt, T. J. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1673 · Cited by 126
Self-citationBiological activity of immunostimulatory CpG DNA motifs in domestic animals
Mutwiri, G., Pontarollo, R. A., Babiuk, S., Griebel, P. J., den Hurk, S. V. D. L., Mena, A., Tsang, C., Alcon, V., Nichani, A., Ioannou, X. P., et al. (2003) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00246-5 · Cited by 126
Askew, D., Chu, R. S., Krieg, A. M., & Harding, C. V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6889 · Cited by 126
Self-citationMandke, P., & Vásquez, K. M. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102701 · Cited by 128
Innate immunity and its role against infections
Uthaisangsook, S., Day, N. K. B., Bahna, S. L., Good, R. A., & Haraguchi, S. (2002) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62005-4 · Cited by 144
Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA
Krieg, A. Μ. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)81515-0 · Cited by 134
Self-citationTechnical and regulatory hurdles for DNA vaccines
Donnelly, J., Berry, K., & Ulmer, J. B. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00056-0 · Cited by 125
Obermeier, F., Dunger, N., Strauch, U., Grunwald, N., HERFARTH, H., Schölmerich, J., & Falk, W. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02288.x · Cited by 125
Leite‐de‐Moraes, M., Lisbonne, M., Arnould, A., Machavoine, F., Herbelin, A., Dy, M., & Schneider, E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1839::aid-immu1839>3.0.co;2-y · Cited by 53
Yeh, D., Liu, Y., Lo, Y.-C., Yuh, C., Yu, G., Lo, J., Luo, Y., Xiang, R., & Chuang, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305273110 · Cited by 137
Ito, T., Schaller, M., Hogaboam, C. M., Standiford, T. J., Sandor, M., Lukacs, N. W., Chensue, S. W., & Kunkel, S. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35647 · Cited by 125
Colombage, G. S. S. K., Hall, R. A., Pavy, M., & Lobigs, M. (1998) · Virology · doi:10.1006/viro.1998.9357 · Cited by 132
Cornélie, S., Hoebeke, J., Schacht, A.-M., Bertin, B., Vicogne, J., Capron, M., & Riveau, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313406200 · Cited by 125
Caccavo, D., Pellegrino, N. M., Altamura, M., Rigon, A., Amati, L., Amoroso, A., & Jirillo, E. (2002) · Journal of Endotoxin Research · doi:10.1179/096805102125001000 · Cited by 116
Biological impediments to monoclonal antibody–based cancer immunotherapy
Christiansen, J., & Rajasekaran, A. K. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1493.3.11 · Cited by 134
Patole, P. S., Pawar, R. D., Lech, M., Zecher, D., Schmidt, H., Segerer, S., Ellwart, A., Henger, A., Kretzler, M., & Anders, H. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl336 · Cited by 136
Guerrero-Plata, A., Baron, S., Poast, J. S., Adegboyega, P. A., Casola, A., & Garofalo, R. P. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10190-10199.2005 · Cited by 125
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.